The Welcome Leap ∆ Tissue Program, The South African Tuberculosis Vaccine Initiative (SATVI) and UCT’s Institute of infectious diseases and Molecular Medicine (IDM) will be co-hosting a mini symposium on Tuesday 19 March 2024 featuring a line-up of internationally renowned Δ Tissue Program researchers. • The minisymposium will provide an opportunity to expose staff, postdocs and students to a stellar group of world leading researchers who will be presenting a series of talks on their work. • The minisymposium will provide an opportunity to network and share scientific expertise between groups based at the IDM and international researchers. • The mini symposium will be an in-person event and places are reserved based on first come first served basis. About Wellcome Leap: Wellcome Leap builds and executes bold, unconventional programs that aim to deliver breakthroughs in human health over 5 – 10 years. Founded by the Wellcome Trust in 2020 as a US nonprofit, Leap programs target complex human health challenges with the goal of achieving breakthrough scientific and technological solutions. Operating at the intersection of life sciences and engineering, Leap programs require best-in-class, multi-disciplinary, global teams assembled from universities, companies, and nonprofits working together to solve problems that they cannot solve alone. Delta Tissue is an Integrated Platforms for Predicting Changes in Tissue State, an international effort that brings experts in the life sciences and engineering together from across universities, foundations, and the private sector to develop a platform that can profile tissue states and predict transitions between states in ways that are impossible today.